Quarterly Result4 Aug 2026, 04:16 pm
Shree Ganesh Biotech Declares Un-audited Q1 FY27 Results
AI Summary
Shree Ganesh Biotech (India) Ltd announced that its Board of Directors, in a meeting held on August 4, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The company operates in a single segment. The financial results were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors. Previous periods' figures have been re-grouped or re-arranged as necessary. Provisions for taxation will be made at year-end.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Results reviewed by Audit Committee and limited reviewed by auditors.
- Company operates in a single business segment.
- Tax provisions to be made at year-end.
- Previous period figures may be re-arranged.
Price Impact
More from SHREEGANES